RARRES3

gene product
HRASLS4, TIG3
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
165 antibodies from 31 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
NovoPro Bioscience Inc.
1 antibody
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
27 antibodies
Novus Biologicals
8 antibodies
antibodies-online
36 antibodies
Aviva Systems Biology
5 antibodies
Abnova Corporation
6 antibodies
OriGene
3 antibodies
ProSci
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Affinity Biosciences
1 antibody
Antibodies.com
1 antibody
Boster Biological Technology
1 antibody
Biorbyt
13 antibodies
Invitrogen Antibodies
5 antibodies
GeneTex
3 antibodies
R&D Systems
2 antibodies
Abgent
2 antibodies
St John's Laboratory
3 antibodies
RabMAbs
1 antibody
Signalway Antibody LLC
1 antibody
MyBioSource
4 antibodies
RayBiotech, Inc.
2 antibodies
Sigma-Aldrich
2 antibodies
Creative Biolabs
1 antibody
EMD Millipore
1 antibody
United States Biological
14 antibodies
Abbexa
3 antibodies
Everest Biotech
1 antibody
GenWay
1 antibody